Overall, circ-SHKBP1 modulated GEC angiogenesis via miR-379/FOXP2 and miR-544a/FOXP1 pathways, and these results could be used in a combination therapy for glioma (He et al., 2018). The gene discussed is SHKBP1; the disease is central nervous system cancer.